Article Information
History
- January 24, 2023.
Article Versions
- Version 1 (February 20, 2021 - 17:42).
- Version 2 (February 21, 2021 - 06:18).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Hayley Porter1,+,
- Yang Li1,+,
- Maria Victoria Neguembor2,
- Manuel Beltran3,
- Wazeer Varsally1,
- Laura Martin2,
- Manuel Tavares Cornejo3,
- Dubravka Pezic1,
- Amandeep Bhamra4,
- Silvia Surinova4,
- Richard G. Jenner3,
- Maria Pia Cosma2,5,6 and
- Suzana Hadjur1,*
- 1Research Department of Cancer Biology, Cancer Institute, University College London, 72 Huntley Street, London, United Kingdom
- 2Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003 Barcelona, Spain
- 3Regulatory Genomics Group, Cancer Institute, University College London, London WC1E 6BT, United Kingdom
- 4Proteomics Research Translational Technology Platform, Cancer Institute, University College London, 72 Huntley Street, London, United Kingdom
- 5Universitat Pompeu Fabra (UPF), Dr Aiguader 88, 08003 Barcelona, Spain
- 6Institució Catalana de Recerca i Estudis Avançats (ICREA), Pg. Lluís Companys 23, 08010 Barcelona, Spain
- ↵*Correspondence: s.hadjur{at}ucl.ac.uk
↵+ These authors contributed equally